electroCore Strengthens Patent Portfolio with Issuance of Four New U.S. Patents
21 sept. 2022 08h00 HE
|
electroCore, Inc.
ROCKAWAY, N.J., Sept. 21, 2022 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that the United States Patent and Trademark...
The Carrick Institute to Host 1-Day Concussion Bootcamp Workshop at 37th World Congress of Sports Medicine
20 sept. 2022 14h00 HE
|
Carrick Institute
GUADALAJARA, Mexico, Sept. 20, 2022 (GLOBE NEWSWIRE) -- The Carrick Institute, world leader in clinical neuroscience education, proudly announced today that they will be delivering a 1-day...
Electrocore Announces Date for Fiscal Year 2022 Annual Meeting and Deadlines for Stockholder Proposals
20 sept. 2022 08h00 HE
|
electroCore, Inc.
ROCKAWAY, N.J., Sept. 20, 2022 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR) (the “Company”), a commercial-stage bioelectronic medicine company, today announced its plans to hold its fiscal...
Odyssey Health Achieves Positive Safety Outcomes for Concussion Drug in Multiple Ascending Dosing Trial, Cohort II
13 sept. 2022 08h00 HE
|
Odyssey Health, Inc
Las Vegas, NV, Sept. 13, 2022 (GLOBE NEWSWIRE) -- Odyssey Health, Inc. (OTC: ODYY), f/k/a Odyssey Group International, Inc., a company focused on developing unique, life-enhancing medical products,...
gammaCore (Non-Invasive Vagus Nerve Stimulation; nVNS) Reduces Symptoms of Acute Withdrawal in Patients with Opioid Use Disorder
07 sept. 2022 08h00 HE
|
electroCore, Inc.
ROCKAWAY, N.J., Sept. 07, 2022 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced the publication of a peer reviewed...
electroCore to Participate at Upcoming Investor Conferences
06 sept. 2022 08h00 HE
|
electroCore, Inc.
ROCKAWAY, N.J., Sept. 06, 2022 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that electroCore’s Chief Executive Officer,...
Odyssey Health Achieves Positive Safety Outcomes for Concussion Drug in Multiple Ascending Dosing Trial
18 août 2022 08h00 HE
|
Odyssey Health, Inc
Las Vegas, NV, Aug. 18, 2022 (GLOBE NEWSWIRE) -- Odyssey Health, Inc. (OTC: ODYY), f/k/a Odyssey Group International, Inc., a company focused on developing unique, life-enhancing medical products,...
Retired NFL Players, Wives Form Player Advocacy Committee to Help Retired Players in the NFL Concussion Settlement; Class Counsel to Support Efforts
16 août 2022 10h00 HE
|
Player Advocacy Committee for the NFL Concussion Settlement
WASHINGTON, Aug. 16, 2022 (GLOBE NEWSWIRE) -- Dr. Amy Lewis, chair of the newly-created Player Advocacy Committee and wife of retired NFL player Kenneth Jenkins, announced a collaboration with Chris...
Odyssey Health, Inc. Announces Positive Results from Its Phase I Multi-Day Ascending Dosing for the Treatment of Concussion
10 août 2022 08h00 HE
|
Odyssey Health, Inc
Las Vegas, NV, Aug. 10, 2022 (GLOBE NEWSWIRE) -- Odyssey Health, Inc. (OTC: ODYY), f/k/a Odyssey Group International, Inc., a company focused on developing unique, life-improving medical products,...
IBN (InvestorBrandNetwork) Announces ‘Get Authentic’ Interview with NFL Hall of Famer Brett Favre and Odyssey Health Inc.’s Dr. Jacob VanLandingham
09 août 2022 08h00 HE
|
InvestorBrandNetwork (IBN)
LOS ANGELES, Aug. 09, 2022 (GLOBE NEWSWIRE) -- via InvestorWire -- IBN, a multifaceted financial news and publishing company for private and public entities, today announces that NFL Hall of Famer...